Eli Lilly & Co
LLY
ISIN null / Valor 947556
Eli Lilly & Co
UMushroom community rating:
About company
Eli Lilly & Co, headquartered in Indianapolis, is a global pharmaceutical company with a significant presence in the healthcare sector. Known for its research, development, and commercialization of pharmaceutical products, Eli Lilly focuses on a wide range of therapeutic areas including but not limited to oncology, diabetes, neurodegeneration, and immunology. The company has recently announced results from a pioneering study of lebrikizumab, a treatment specifically designed for individuals with skin of color suffering from moderate-to-severe atopic dermatitis, also known as eczema. This highlights Eli Lilly's commitment to addressing diverse medical needs and expanding its portfolio to include treatments tailored for specific demographic groups. The company's efforts in innovation and targeted research underscore its role in advancing medical treatments and improving patient outcomes across various disease states.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
833890 M
Market cap (USD)
4,463,679
Daily traded volume (Shares)
779.59 / 771.02
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Mael Caparelli
Gabriele Saponara Teutonico
Laxsijan Selvaratnam
EQUITIES OF THE SAME SECTOR
